MUMBAI, India, Sept. 7 -- Intellectual Property India has published a patent application (202617082245 A) filed by Daewoong Pharmaceutical Co. , Ltd. on July 03, 2026, for Novel Heterocyclic Compounds And Pharmaceutical Composition Comprising The Same.
Inventors include Cao, Bin; Tian, Ye; Qin, Li; Jiang, Yan; Zhao, Liyu; and Dou, Guosheng.
The application for the patent was published on September 04, 2026, under issue no. 36/2026.
Abstract: The present disclosure relates to a novel heterocyclic compound represented by the Chemical Formula 1 and a pharmaceutical composition comprising the same, and the compound according to the present disclosure can be usefully used for the prevention or treatment of cancer. [Chemical Formula 1] in Chemical Formula 1, A, L1, R1, B, R2, R3, L2, R4, and R5 are as defined in the specification.
Disclaimer: Curated by HT Syndication.
